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Abstract 
Albumin was conjugated to 16 nm gold particles 
(Alb-Au 16) and infused into anesthetized pigs to deter-
mine if plasma, tissue and bronchoalveolar lavage (BAL) 
fluid concentrations of gold could be quantitated by neu-
tron activation (Au198). Additionally, transmission elec-
tron microscopy (TEM) of lung and liver samples was 
evaluated for sites of gold distribution and morphological 
changes. The minimum concentration of gold detected 
by neutron activation ranged between 1.4 and 1.9 ppb 
(ng/gm of sample) . No gold was detected in the plasma 
of pigs prior to Alb-Au 16 infusion, while mean post in-
fusion concentration s were 1.037 ± 0.69 ppm (µg/gm 
plasma, ±SD). The concentrations in the lung and liver 
were 274.4 ± 0.03 and 88.3 ± 0.04 ppm, respectively. 
There was no measurable Alb-Au 16 in the BAL fluid . 
TEM showed gold particles within phagolysosomes in 
pulmonary and hepatic intravascular macrophage s. No 
morphological changes were observed within the two 
populations of macrophages and no gold particle s were 
observed within the alveolar space . Neutron activation 
of blood , tissue and BAL fluid samples from pigs 
administered intravenous Alb-Au 16 was sensitive to the 
ppb concentration. The capability of neutron activation 
to detect very low concentrations of Au 198, combined 
with the freedom from contamination, make neutron 
activation an excellent technique for the study of the 
distribution and metabolism of a substance in vivo. 
Key Words: Colloidal gold, intravascular macrophages, 
neutron activation , pig , electron microscopy, correlative 
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Introduction 
Colloidal gold has been used extensively to study 
structural and ultrastructural cellular components and 
functions [1, 4, 8, 10, 14, 19, 29] . Colloidal gold parti-
cles are easily observed by scanning and transmission 
electron microscopy (SEM and TEM, respectively). 
Video-enhanced light microscopy (LM) is useful to de-
tect larger gold particles(> 15 nm) or groups of small-
er particles on flat thin specimens, due to the inflated 
diffraction image of the colloidal gold [2, 3, 15]. With 
respect to endotoxin-mediated lung injury, immunogold 
labeling has proven to be a useful marker of endotoxin-
macrophage receptor binding and endocytosis and neu-
trophil- endothelial cell adhesion, activation and migra-
tion [5, 12, 17, 21, 23, 24, 27, 31]. Albumin is largely 
responsible for the oncotic pressure of plasma and inter-
stitial fluid and is transported through pulmonary capil-
laries by receptor-mediated transcytosis; consequently, 
albumin gold may be a useful indicator for the morpho-
logical assessment of altered permeability [15, 34, 35, 
36]. Albumin-gold, taken up by various organs and 
tissues after being administered intravenously, can be 
quantitated by neutron activation (Au197 + 'Y.,,. Au198) 
[7, 18, 22, 28, 32, 33]. 
The present study was designed to determine wheth-
er systemic administration of albumin colloidal gold 
could be quantitated in the plasma, liver, lung and bron-
choalveolar lavage and correlated with liver and lung 
morphology . Our previous preliminary studies in ponies 
(Woods, Ginther and Albrecht, unpublished) demonstrat-
ed the potential of this approach to determine compound 
distribution in large animals . Since the neutron 
activation step is performed on tissue or fluids subse-
quent to their collection, no exposure of the animals to 
radioactivity or radioactive compounds is necessary . 
For this work, we employed a previously described 
model system used to investigate gram-negative septic 
shock in pigs [20, 25]. Gram-negative septic shock is 
associated with life-threatening hemodynamic and meta-
bolic decompensation, which is mediated, in part, by in-
flammatory mediators released in response to bacterial 
endotoxin [16, 30]. The lung is particularly susceptible 
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to acute injury in septic shock because it produces in-
flammatory mediators from intravascular and alveolar 
macrophages and pro-thrombin factors from both endo-
thelial cells and macrophages which potentiate neutrophil 
infiltration and microvascular permeability, respectively 
[6, 11]. In this study, we investigated the feasibility of 
correlating bulk concentrations of albumin colloidal gold 
in plasma, liver, lung and bronchoalveolar lavage fluid 
with tissue morphology to determine the exact location 
of the colloidal gold labeled albumin relative to tissue 
and cell structure changes in normal animals. If suc-
cessful, this technique would be applied to a porcine 
model of acute lung injury in order to evaluate the distri-
bution and fate of gold labeled albumin during endo-
toxemia [23, 25, 39). 
Materials and Methods 
Albumin gold preparation 
Colloidal gold particles were prepared by reducing 
chloroauric acid with tannic acid and sodium citrate [26, 
37]. The colloidal gold sol was pH adjusted with 0.2 N 
K2CO3 to pH 7.0, basic to the isoelectric point of bo-
vine serum albumin (BSA; Sigma, St. Louis, MO) and 
filtered through a 0.45 µm filter. A stable conjugate of 
Alb-Au 16 was achieved at 180 µg of BSA/ml of gold, as 
determined by the salt flocculation test. Twelve liters of 
Alb-Au 16 were conjugated at one time to minimize con-
jugate variability. Prior to use, the albumin-gold was 
concentrated 80 fold by centrifugation (15,000 g, 30 
minutes) and 50 ml of concentrate, extended to 60 ml 
with phosphate buffered saline, was infused into each 
pig. 
Animal preparation 
Two eight- to twelve-week -old pigs were anesthe-
tized and maintained using standard procedures employ-
ing pentobarbital sodium, as previously described [25]. 
The pigs were placed in supine position and were me-
chanically ventilated via tracheostomy at a constant tidal 
volume and rate (Edco Scientific Inc., Chapel Hill, NC) . 
Pigs were instrumented for standard cardiopulmonary 
measurements, allowed to stabilize for a minimum of 30 
minutes and administered Lactated Ringers solution 
(Baxter-Travenol, Deerfield, IL) at 5 ml/kg/hr through 
a jugular vein to help maintain circulating blood volume 
and pressure for 6 hours. At 5.25 hours, 60 ml of con-
centrated Alb-Au 16 was infused at a rate of 2 ml/min for 
30 minutes. Blood samples were obtained at hours 5 
and 6 for quantitation of plasma Alb-Au 16. At 6 hours, 
bronchoalveolar lavage (BAL) fluid, and lung and liver 
tissue samples were obtained from the left cardiac and 
right central lobes, respectively. The BAL fluid was 
collected by infusing 80 ml of phosphate buffered saline 
into each bronchus and gently massaging the lobes while 
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aspirating the BAL fluid. Neutron activation samples 
were weighed in 2/5 dram polyethylene flip-top vials for 
Alb-Au 16 quantification. The intermediate lobe was 
fixed with 10 % phosphate buffered formalin for 5 min-
utes by airway and vascular perfusion. Sagittal sections 
were then collected caudal to the major bronchus, fixed 
for 2 hours at room temperature (22°C) in Kamovsky's 
solution (2 % paraformaldehyde and 1.25 % glutaralde-
hyde) with 0.1 M cacodylate buffer and then rinsed and 
stored under refrigeration in 0.1 M cacodylate buffer. 
The tissues were routinely prepared for TEM (i.e., post-
fixed in osmium tetroxide, serially dehydrated and em-
bedded in Epon Araldite). Semi-thin sections (1.0 µm) 
were stained with 0.1 % toluidine blue for orientation 
and evaluation of lesions . Thin sections (60-70 nm) 
were cut on a Reichert Ultracut E Ultramicrotome fitted 
with Diamond Knife (Diatome, Bienne, Switzerland), 
placed on copper grids (E. Fullam, Latham, NY), stain-
ed with 1 % uranyl acetate, followed with lead citrate, 
and examined on a Phillips 410 transmission electron 
rmcroscope. 
Neutron activation 
Neutron activation studies were performed at the 
University of Wisconsin, Nuclear Reactor Laboratory, 
in a 1 M TRIGA open pool reactor, in the department of 
Nuclear Engineering and Engineering Physics. Vials 
without contents (blanks) and vials containing samples 
and standards of liquid Au solution were sealed by fric-
tion welding . The blank vials were analyzed to deter-
mine the gold content of the polyethylene. In batches of 
8 unknown samples and one standard, the vials were ex-
posed for 60 minutes to the same thermal neutron flux 
(1 x 1013 neutrons/cm 2-sec) by rotating the sample car-
rier about its axis during irradiation . Four days post ir-
radiation, the samples were counted for 3600 seconds at 
2 cm on the vertical axis of a r-ray detector (170 cm3, 
aortic intrinsic germanium detector, #GEM 40190 , 
Ortec , Oak Ridge, TN) coupled to a PC based multi-
channel r-ray spectrometer using a PAC-II MCA board 
(Oxford Analytical Systems, Oak Ridge, TN). Photo-
peak areas were corrected to saturation activity and 
corrected for any known interfering gamma rays. Neu-
tron flux was calculated based on the selected element 
(Au197) in the standard, using a library of element data 
and detector efficiencies . Conversion factors in this 
library were standardized to the standard samples (10 
and 100 ppm, µg Au198/gm of sample) run with the un-
known samples. Neutron flux calculations, which as-
sume only thermal neutron activation, facilitate the com-
parison of standards from group to group to assure they 
were counted in approximately the same flux. 
For each sample, the decay time (the time from the 
end of the irradiation to the start of the count), the live 
Colloidal gold and neutron activation 
time (the number of seconds the counter was available 
to proces s data during the counting period), and the frac-
tional dead time (a measure of the counting time lost 
while processing pulses) were determined [9, 13]. The 
decay and live times were used to correct for radioactive 
decay and compute counts/second, respectively. The 
fractional dead time was used to correct for loss of 
pulses from the spectrum while processing pulses. For 
each element measured, the energy (keV) and counts/ 
second for that r-ray, and the standard deviation of the 
measured count rate were calculated. If an element was 
detected in the sample, and the material was certified for 
that element in the standard, the micrograms of element/ 
gram of material was calculated from the count-rate 
date. To determine the precision of the photopeak: area 
(which yields counts per second) the percentage standard 
deviation (%SD) was calculated from Poisson statistics 
using the net photopeak: area and the background on 
which the photopeak: is riding, and subtracting any inter-
fering elements contributing to the photopeak. The mass 
of gold present in each sample was expressed in micro-
grams, and the fractional portion of gold in the unknown 
samples was expressed in micrograms per gram of sam-
ple (parts per million, ppm). For liquid samples (plasma 
and BAL fluid), the fractional portion was expressed as 
micrograms per milliliter. The amount of gold in each 
unknown sample was determined by subtracting the 
mean gold value of the blank vials from the gold 
quantitated for the unknown. 
Results 
Neutron activation 
The mean amount of gold detected by neutron acti-
vation in the empty (blank) vials was 1.6 ng/gm of sam-
ple (ppb) (range 1.4 - 1.9 ppb), and neutron activated 
liquid gold standards were quantitated at 10 and 100 
ppm (µg Au198tgm of sample) (Table 1). There was no 
detectable gold in the plasma of the pigs prior to the 
Alb-Au 16 infusion, while mean post infusion concentra-
tions were 1.037 ± 0.69 ppm (µg/gm plasma ± SD). 
The concentrations of Alb-Au 16
198 in the lung and liver 
were 274.4 ± 0.03 and 8.83 ± 0.04 ppm, respectively . 
There was no measurable amounts of Alb-Au16 in the 
BAL fluid. 
Transmission electron microscopy 
On TEM, Alb-Au 16 was observed within phagolyso-
somes in pulmonary and hepatic intravascular macro-
phages (Figs. 1 and 2). The gold particles were ob-
served within phagolysosomes. No observable morpho-
logical changes to the pulmonary and hepatic microvas-
culature and macrophages were observed. Additionally, 
gold particles were not observed in the alveolar space. 
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Table 1. Quantitation of neutron activated colloidal al-
bumin-gold (Alb-Au16
198) in the plasma, lung, liver and 
bronchoalveolar lavage (BAL) fluid. Value = total µg 
Au198 minus background in polyethylene vial (1.6 X 
10-3 ppm). 
Sample 
Plasma (pre Au198) 




Neutron activated Au198 ppm 
(µg/gm sample ± % SD) 
0.0 (~ background) 
1.037 ppm ± 0.69 
274.4 ppm ± 0.03 
88.3 ppm ± 0.04 
0.0 (~ background) 
Discussion 
Neutron activation analysis is the measurement of 
radioactive isotopes produced from the bombardment of 
an element (i.e., gold, Au197) by neutron or other high-
energy nuclear particles. We activated gold with a flux 
of thermal neutrons, thus creating the reaction 
Au197(n,r) ~ Au 198, where Au198 is the radioactive iso-
tope. Au198 is a nuclide with a relatively short half-life 
(2. 7 days) and emits a r ray and {3 particles with ener-
gies of 411 ke V and 963 ke V, respectively. If the bom-
bardment conditions are kept constant at the time the 
standards and unknown samples are activated, then the 
resultant nuclide is directly proportional to the weight of 
the target material in the unknown sample [38]. Rotat-
ing the sample carrier during the irradiation process en-
sured that all samples received the same amount of ther-
mal neutron flux. The thermal neutron activation cross 
section of gold is large (u
8
c = 96 ± 10 barn), a fact 
which favors its use by neutron activation, and Au 198 
has a detector efficiency which lends itself to easy and 
accurate analysis, therefore making quantitationextreme-
Iy specific. Additionally, because quantitation of Au 198 
is very sensitive (1 x 10-9g Au198/gm of sample, ppb), 
it is very useful in the detection of an extremely small 
amount of substance, thus making the technique suitable 
for studying the fate and distribution in animals weighing 
up to 20 kg and more. 
The advantage of irradiating samples post mortem 
is that it eliminates introducing a fairly strong radio-
nuclide in studies of distribution and metabolism of a 
substance in vivo. It is also possible that what is ob-
served in an in vivo study with a radioactive substance 
may be different from that which would have occurred 
if a non-radioactive substance was administered [18]. 
Relative freedom from contamination and the very low 
detection limits of neutron activation make it an 
B.J . Dari en et al. 
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Figure 1. (a) Alveolar septal 
capillary contammg erythrocyte 
and pulmonary intravascular mac-
rophage (PIM). Arrow heads 
mark phagolysosomes. N = nu-
cleus of PIM; R = red blood cell; 
A = alveolus. Bar = 0.1 µm. 
(b) Higher magnification of Figure 
la; arrowheads point to phagolyso-
somes which contain numerous 
gold particles . 
Figure 2. (a) Hepatocytes mar-
ginating sinusoid containing 
erythrocyte and Kupffer cell. 
Arrowheads mark phagolysosomes. 
N = nucleus of Kupffer cell; H = 
hepatocyte. Bar = 0.1 µm . (b) 
Higher magnification of Figure 2a; 
arrowheads point to phagolyso-
somes which contain numerous 
gold particles . 
Colloidal gold and neutron activation 
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excellent technique for the ex vivo analysis of gold as 
well as other selected elements [19, 36]. 
The molecular species can be produced in several 
forms. Individual molecules or active fragments can be 
conjugated to very small, 2-5 nm, gold particles which 
are smaller than the molecules being evaluated. Larger 
gold particles, 15-30 nm, can be used to form larger 
probes by condensing the gold particle with one or more 
active molecules attached to it [36]. While the larger 
gold particles are readily visible by electron microscopy, 
the smaller gold particles can be enlarged, following 
labeling, with silver enhancement to improve their 
visualization in SEM, TEM, or LM. Tissue samples 
can be divided and a portion prepared for electron mi-
croscopy analysis prior to neutron irradiation. Addition-
ally, for inorganic samples, the small amount of radioac-
tive material, short half-life, and a and (J emission prop-
erties do not preciude examination of irradiated samples. 
Results of this study demonstrate the feasibility of 
performing sensitive quantitative assays of the amount of 
gold label present in a given tissue or location and 
correlative electron microscopy observations of the tis-
sue in order to determine the precise location of label 
relative to tissue, cellular and subcellular structures [40]. 
During endotoxemia, there is profound immune sup-
pression and impaired peritoneal and mononuclear phag-
ocytic clearance of bacteria, which predisposes the host 
to increased susceptibility to bacterial dissemination and 
to the risk of developing acute respiratory distress syn-
drome and multiple organ failure [12, 21, 23]. Neutron 
activation of tissue (liver and lung), plasma and BAL 
fluid following endotoxemia may provide a means by 
which to study two dynamic pathophysiological events, 
specifically, mononuclear phagocytic dysfunction and 
microvascular injury and permeability. Concomitant 
with changes would be the opportunity to evaluate mor-
phologic changes by SEM, TEM or LM . 
It should be noted that, as indicated in Materials 
and Methods, the colloidal gold was synthesized and 
conjugated to albumin in our laboratory. While we rou-
tinely prepare our own gold and gold conjugates for a 
number of antibody and ligand labeling procedures, it is 
of added importance in studies such as these. The total 
cost, materials and time, to prepare the 12 liters of gold-
albumin was approximately $100. If the materials were 
purchased commercially, the cost would be considerably 
more. 
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Discussion with Reviewers 
M. Jacques: Would you expect similar results if uncon-
jugated gold particles were infused into pigs? What is 
the effect of albumin on gold distribution? 
Authors: Colloidal gold is a hydrophobe sol which 
would quickly aggregate in the presence of physiological 
salt concentrations in blood . This would probably result 
in large aggregates \.vhich would become coated with 
available serum proteins, including albumin. These large 
aggregates would ultimately be phagocytized. Albumin 
is used to coat the gold particles so they remain as indi-
vidual particles in the circulation. Albumin was chosen 
because it is nonadhesive, has a relatively long half life, 
and while there may be localized cell binding sites which 
facilitate albumin uptake, albumin is not thought to have 
receptor mediated signal transducing activity. 
M. Jacques : Your rationale is to use gold conjugates to 
study microvascular injury and permeability. The size of 
the probe will certainly influence its diffusion. You 
should have compared gold particles of different diame-
ters (e.g., 3-5 run, 16 nm, and 25-30 nm). Why did you 
use 16 run gold particles? 
J. Hobot : Is there any advantage in using smaller gold 
particles (2-3 nm or less) than those of 15-30 nm, in 
terms of easier passage or permeability through body or 
cellular channels? 
Authors: The purpose of the present study was to show 
that neutron activation had sufficient sensitivity to quanti-
tate the extremely small amount of gold used and also to 
demonstrate neutron activation could be correlated with 
electron microscopy to show the location of the gold par-
ticles, in addition to their bulk concentration. We are 
presently testing various sized particles. It is also impor-
tant to note that the overall probe size is the gold core 
plus the shell of adsorbed protein. With the small gold 
particles, a single particle intercalates into the molecule 
such that the probe size is usually equivalent to the size 
of a single protein molecule. This is best for studies of 
the fate of soluble molecules, whereas larger gold parti-
cles with multiple bound protein molecules are better for 
studying the fate of aggregates . We used the 16 nm par-
ticle because the final probe size with adsorbed albumin 
is roughly 20 - 22 nm, equivalent of small aggregates 
which can leave through spaces in permeable vascular 
endothelium but are also normally phagocytosed. 
J. Hobot: What other proteins can be conjugated to col-
loidal gold and used in the neutron activation studies? 
Have other proteins been tried? Is the sensitivity of neu-
tron activation of particles independent of particle size? 
Authors: In theory, any protein can be used. Most pro-
teins, under appropriate conditions, bind very strongly 
by hydrophobic bonding to the gold and are as stable in 
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vivo as the unconjugated protein. To date, we have not 
used other proteins in vivo, although many have been 
used in in vitro studies. Quantitation by neutron activa-
tion is only related to the amount of gold, not the ad-
sorbed protein or particle size. 
J. Hobot: When gold is conjugated to albumin (or per-
haps another protein of interest) and injected into an ani-
mal, would not the animal's immune system treat the 
gold as an unwanted invader and react accordingly, such 
that the distribution of albumin-gold is adversely 
affected? 
Authors: In the present study, the time periods are far 
too short for the host to mount an immune response un-
less prior sensitization has occurred. Foreign proteins of 
any kind will trigger a specific immune response whether 
or not it is conjugated to gold. For "self" proteins to be 
recognized as foreign, new "non-self" epitopes must be 
created. Binding of "self" proteins to various metals, 
such as nickel, is thought to be a basis for change in 
antigenicity and possibly subsequent immune mediated 
skin sensitivity. In the case of colloidal gold, various 
molecular species bind to gold via random hydrophobic 
bonding, although preferred locations in proteins do 
exist, due to highly charged or hydrophobic areas, etc. 
The activity and antigenicity appear relatively unaffected. 
Although the potential to trigger an immune response by 
epitope modification may exist, so far data is insufficient 
to predict the outcome. 
B. Humbel: First of all, it should be proven that albu-
min gold follows the same pathway as uncoupled albu-
min. In the Discussion, the authors state "It is also pos-
sible that what is observed in an in vivo study with a ra-
dioactive substance may be different from that which 
would have occurred if a non-radioactive substance was 
administered." There is no reason why a gold particle 
bound to many BSA molecules should be more reliable 
than albumin with a radioactive tracer. In fact, this 
control experiment is missing. 
Authors : Our intent was to demonstrate first that col-
loidal gold coupled molecular species, in this case albu-
min, could be quantitated in bulk samples of different tis-
sues or in blood by the neutron activation procedure. 
Second, we wished to show that correlative electron mi-
croscopy could be performed to see qualitatively where 
in the tissues the gold was located. We did not intend to 
imply that Alb-Au 16 (roughly 22 nm total diameter) 
would behave as soluble albumin. In fact, we chose the 
larger particles to demonstrate differences in phagocytic 
clearance of particulates. The use of 2 or 3 run gold, 
which would result in single albumin molecules conjuga-
ted to a smaller gold particle, would be expected to be-
have more like soluble albumin but, control studies using 
radiolabeled albumin would be important to verify this. 
